REFERENCES
3. Banzai A, Sugiyama H, Hasegawa M, Morishima Y, Kawakami Y. Paragonimus westermani metacercariae in two freshwater crab species in Kagoshima Prefecture, Japan, as a possible source of infection in wild boars and sika deer. J Vet Med Sci 2021;83:412-8.
4. Health Organization Study Group. Control of foodborne trematode infections. World Health Organ Tech Rep Ser 1995:849;1-157.
6. Yoshida A, Doanh PN, Maruyama H. Paragonimus and paragonimiasis in Asia: An update. Acta Trop 2019;199:105074.
7. Calvopiña M, Romero D, Castañeda B, Hashiguchi Y, Sugiyama H. Current status of Paragonimus and paragonimiasis in Ecuador. Mem Inst Oswaldo Cruz 2014;109:849-55.
8. Sharma DC. Paragonimiasis causing diagnostic confusion with tuberculosis. Lancet Infect Dis 2005;5:538.
9. Shu QH, Yang Y, Li SD, et al. Analysis of the misdiagnosis of 8 adult cases of paragonimiasis with lung masses as the main manifestation in Xishuangbanna, Yunnan. J Cardiothorac Surg 2021;16:28.
10. Parikh MS, Seeley E, Krishna G. Electromagnetic navigational bronchoscopy spares a drunken crab from the surgeon’s knife. J Bronchology Interv Pulmonol 2017;24:241-3.
11. Oh IJ, Kim YI, Chi SY, et al. Can pleuropulmonary paragonimiasis be cured by only the 1st set of chemotherapy? Intern Med 2011;50:1365-70.
12. Feng Y, Fürst T, Liu L, Yang GJ. Estimation of disability weight for paragonimiasis: a systematic analysis. Infect Dis Poverty 2018;7:110.
13. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
14. Rim HJ, Chang YS, Lee JS, Joo KH, Suh WH, Tsuji M. Clinical Evaluation Of Praziquantel(Embay 8440; Biltricide(R)) In The Treatment Of Paragonimus Westermani. Kisaengchunghak Chapchi 1981;19:27-37.
15. Cao WJ, He LY, Zhong HL, Xu ZS, Bi YC, et al. Paragonimiasis: treatment with praziquantel in 40 human cases and in 1 cat. Arzneimittelforschung 1984;34:1203-4.
16. Knobloch J, Paz G, Feldmeier H, Wegner D, Voelker J. Serum antibody levels in human paragonimiasis before and after therapy with praziquantel. T Roy Soc Trop Med H 1984;78:835-6.
17. Udonsi JK. Clinical field trials of praziquantel in pulmonary paragonimiasis due to Paragonimus uterobilateralis in endemic populations of the Igwun Basin, Nigeria. Trop Med Parasitol 1989;40:65-8.
18. Moyou-Somo R, Tagni-Zukam D. [Paragonimiasis in Cameroon: clinicoradiologic features and treatment outcome]. Med Trop (Mars) 2003;63:163-7.
19. Calvopiña M, Guderian RH, Paredes W, Chico M, Cooper PJ. Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. T Roy Soc Trop Med H 1998;92:566-9.
20. Calvopiña H, Guderian RH, Paredes WY, J. Cooper P. Comparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis. T Roy Soc Trop Med H 2003;97:451-4.
21. Ripert C, Couprie B, Moyou R, Gaillard F, Appriou M, Tribouley-duret J. Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroon: a pilot study. T Roy Soc Trop Med H 1992;86:417.
22. Hu P, Liu YH. [A clinical trial of triclabendazole in the treatment of human paragonimiasis skrjabini]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2001;19:305-7.
23. Ming-gang C, Zheng-shan C, Xiang-yuan S, Ming-da L, Blair D, et al. Paragonimiasis in Yongjia County, Zhejiang Province, China: clinical, parasitological and karyotypic studies on Paragonimus westermani. Southeast Asian J Trop Med Public Health 2001;32:760-9.
24. Gao J, Liu Y, Wang X, Hu P. Triclabendazole in the treatment of paragonimiasis skrjabini. Chin Med J (Engl) 2003;116:1683-6.
25. Chen J, Chen Z, Lin J, et al. Cerebral paragonimiasis: a retrospective analysis of 89 cases. Clin Neurol Neurosurg 2013;115:546-51.
26. Xia Y, Ju Y, Chen J, You C. Cerebral paragonimiasis: a retrospective analysis of 27 cases. J Neurosurg Pediatr 2015;15:101-6.
27. Hu Y, Qian J, Yang D, Zheng X. Pleuropulmonary paragonimiasis with migrated lesions cured by multiple therapies. Indian J Pathol Microbiol 2016;59:56-8.
28. Gong Z, Miao R, Shu M, et al. Paragonimiasis in Children in Southwest China: A retrospective case reports review from 2005 to 2016. Medicine (Baltimore) 2017;96:e7265.
29. Liang T, Liang G, Du Y, et al. Scrotal Paragonimiasis in adults: Two case reports and review of literature. Medicine (Baltimore) 2018;97:e0328.
31. Wu Y, Zhou Y, Jin X, et al. Diagnosis and surgical management of pericardial effusion due to paragonimiasis. Int J Infect Dis 2019;83:102-8.
32. Wang Q, Hou L, Liu L. Diagnosis and treatment of hemorrhagic cerebral paragonimiasis: three case reports and literature review. Turk Neurosurg 2020;30:624-8.
33. Qian M, Li F, Zhang Y, Qiao Z, Shi Y, Shen J. A retrospective clinical analysis of pediatric paragonimiasis in a Chinese children’s hospital from 2011 to 2019. Sci Rep 2021;11:2005.
34. Yatera K, Hanaka M, Hanaka T, et al. A rare case of paragonimiasis miyazakii with lung involvement diagnosed 7 years after infection: a case report and literature review. Parasitol Int 2015;64:274-80.
35. Akaba T, Takeyama K, Toriyama M, et al. Pulmonary paragonimiasis: the detection of a worm migration track as a diagnostic clue for uncertain eosinophilic pleural effusion. Intern Med 2016;55:503-6.
36. Itoh N, Tsukahara M, Yamasaki H, Morishima Y, Sugiyama H, Kurai H. Paragonimus westermani infection mimicking recurrent lung cancer: a case report. J Infect Chemother 2016;22:815-8.
37. Nureki SI, Ishii K, Fujisaki H, et al. Familial mediterranean fever with rheumatoid arthritis complicated by pulmonary paragonimiasis. Intern Med 2016;55:2889-92.
38. Harada T, Kawasaki Y, Tsukada A, et al. Bronchodilator reversibility occurring during the acute phase of paragonimiasis westermani infection. Intern Med 2019;58:297-300.
39. Ogata H, Harada E, Moriya S, et al. Pleuropulmonary paragonimiasis with multiple nodules in the pleura. Intern Med 2020;59:1879-81.
40. Kyung SY, Cho YK, Kim YJ, et al. A paragonimiasis patient with allergic reaction to praziquantel and resistance to triclabendazole: successful treatment after desensitization to praziquantel. Korean J Parasitol 2011;49:73-7.
41. Liu CT, Chen YC, Chen TH, Barghouth U, Fan CK. Intestinal paragonimiasis with colonic ulcer and hematochezia in an elderly Taiwanese woman. Korean J Parasitol 2012;50:349-52.
42. Ponnampalavanar S, Kukreja A, Amir A, Mahmud R. First case report of paragonimiasis in a Malaysian man. Trop Biomed 2020;37:24-8.
43. Petborom P, Linasmita P, Kulpraneet M. Coinfection of pulmonary paragonimiasis and pulmonary tuberculosis in Thailand. J Med Assoc Thai 2016;99 Suppl 8:S231-s6.
44. Gaire D, Sharma S, Poudel K, Pant P. Unresolving pneumonia with pleural effusion: pulmonary paragonimiasis. JNMA J Nepal Med Assoc 2017;56:268-70.
45. Sah R, Gupta N, Chatterji P, et al. Case report: paragonimiasis presenting with pericardial tamponade. Am J Trop Med Hyg 2019;101:62-4.
46. Calvopina M, Romero-Alvarez D, Macias R, Sugiyama H. Severe pleuropulmonary paragonimiasis caused by paragonimus mexicanus treated as tuberculosis in Ecuador. Am J Trop Med Hyg 2017;96:97-9.
47. Calvopiña M, Paredes W, Guderian R, Poltera AA. Eficacia del triclabendazole en paragonimiasis pulmonar humana refractaria a la emetina, bithionol y praziquantel. Parasitol día 1993;17:44-6.
48. Vélez IDB, Ortega J, Hurtado MIM, et al. Epidemiology of paragonimiasis in Colombia. T Roy Soc Trop Med H 2000;94:661-3.
49. Agramonte VF, Ormeño Julca AJ, Coveñas Coronado CDP, Polar Córdova V, Belloso Rodríguez JA. [Pulmonary paragonimiasis. Pediatric case report]. Arch Argent Pediatr 2019;117:e659-63.
50. for Disease Control and Prevention (CDC). Human paragonimiasis after eating raw or undercooked crayfish - Missouri, July 2006-September 2010. MMWR. Morb Mortal Wkly Rep 2010;59:1573-6.
51. Johannesen E, Nguyen V. Paragonimus kellicotti: a lung infection in our own backyard. Case Rep Pathol 2016;2016:2107372.
52. Horn CB, Patel NR, Hawasli JA, Edwards MA. Paragonimus kellicotti presenting with hemoptysis and a left upper lobe mass. Ann Thorac Surg 2016;102:e393-5.
53. A [Endemic pulmonary paragonimiasis in Lower Mundani (Fontem district of southwest Cameroon). Results of treatment with praziquantel]. Bull Soc Pathol Exot 1985;78:334-41.
54. Li R. [Clinical observation of treating 44 cases of paragonimiasis (Paragonimus westermani) with praziquantel (Author’s transl)]. Zhonghua Nei Ke Za Zhi 1982;21:37-8.
55. Cui J, Wang Z, Wu F, Jin X. An outbreak of paragonimiosis in Zhengzhou city, China. Acta Tropica 1998;70:211-6.
56. Vanijanonta S, Radomyos P, Bunnag D, Harinasuta T. Pulmonary paragonimiasis with expectoration of worms: a case report. Southeast Asian J Trop Med Public Health 1981;12:104-6.
57. Johnson RJ, Johnson JR. Paragonimiasis in Indochinese refugees. Roentgenographic findings with clinical correlations. Am Rev Respir Dis 1983;128:534-8.
58. Mariano EG, Borja SR, Vruno MJ. A human infection with paragonimus kellicotti (lung fluke) in the United States. Am J Clin Pathol 1986;86:685-7.
59. Knöll P, Perlewitz J. [Differential diagnosis of paragonimiasis in relation to tuberculosis of the lung by transthoracic needle biopsy]. Z Erkr Atmungsorgane 1986;167:152-7.
60. Añaños G, Trilla A, Graus F, Mas J, Corachán M, Soriano E. [Paragonimiasis and pulmonary tuberculosis]. Med Clin (Barc) 1992;98:257-9.
61. Itakura M, Shinozaki T, Shingyouji M. [A case of Paragonimus Miyazaki with pleuritis and meningoencephalitis]. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:980-4.
62. Doutsu Y, Taniguchi H, Ashitani J, et al. [A case of paragonimiasis westermani diagnosed on the observation of parasitic ova in bronchial washing fluid and successfully treated with praziquantel]. Kansenshogaku Zasshi 1993;67:491-5.
63. Kaneki T, Kubo K, Tanaka N, et al. [A case of paragonimiasis westermani]. Nihon Kokyuki Gakkai Zasshi 1998;36:623-6.
64. Guiard-Schmid JB, Lacombe K, Osman D, et al. [Paragonimiasis: a rare little known disease]. Presse Med 1998;27:1835-7.
65. Kojima T, Takase K, Kasakura N. [Paragonimiasis Miyazakii with variable X-ray shadows]. Nihon Kokyuki Gakkai Zasshi 1999;37:710-4.
66. Aka NA, Allabi AC, Dreyfuss G, et al. [Epidemiological observations on the first case of human paragonimiasis and potential intermediate hosts of Paragonimus sp. in Benin]. Bull Soc Pathol Exot 1999;92:191-4.
67. Jeong MG, Yu JS, Kim KW, et al. Retroperitoneal paragonimiasis: a case of ectopic paragonimiasis presenting as periureteral masses. J Comput Assist Tomogr 1999;23:696-8.
68. Keiser J, Engels D, Büscher G, Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 2005;14:1513-26.
69. Cumberlidge N, Rollinson D, Vercruysse J, Tchuem Tchuenté LA, Webster B, Clark PF. Paragonimus and paragonimiasis in West and Central Africa: unresolved questions. Parasitology 2018;145:1748-57.
70. M, Gabriël S, Abatih EN, Praet N, Benitez W, Dorny P. Taenia solium human cysticercosis: a systematic review of sero-epidemiological data from endemic zones around the world. PLoS Negl Trop Dis 2015;9:e0003919.
71. Vargas-Calla A, Gomez-Puerta LA, Calcina J, et al. Evaluation of activity of triclabendazole against taenia solium metacestode in naturally infected pigs. Asian Pac J Trop Med 2016;9:23-6.
